HomePTKFY • OTCMKTS
add
PT Kalbe Farma Unsponsored Indonesia ADR
Market news
Financials
Income Statement
Revenue
Net income
| (IDR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 7.91T | 7.16% |
Operating expense | 2.29T | 15.55% |
Net income | 573.28B | 6.97% |
Net profit margin | 7.25 | -0.14% |
Earnings per share | 12.41 | 7.73% |
EBITDA | 874.81B | 1.14% |
Effective tax rate | 23.01% | — |
Balance Sheet
Total assets
Total liabilities
| (IDR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.32T | 45.45% |
Total assets | 28.75T | 5.78% |
Total liabilities | 4.84T | 0.67% |
Total equity | 23.91T | — |
Shares outstanding | 46.15B | — |
Price to book | 0.04 | — |
Return on assets | 6.15% | — |
Return on capital | 7.16% | — |
Cash Flow
Net change in cash
| (IDR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 573.28B | 6.97% |
Cash from operations | 1.16T | 22.56% |
Cash from investing | -176.64B | 33.78% |
Cash from financing | -421.11B | 51.91% |
Net change in cash | 481.86B | 1,978.42% |
Free cash flow | 752.00B | 13.84% |
About
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. Wikipedia
Founded
Sep 10, 1966
Website
Employees
12,924
